Biotek-snakken — April 2024
-
Er Cantargia på vej op af hullet…..fra bunden omkring 2,6 i midten af marts, til 4,5 nu…..opkøbsemne?
-
Aps invest, der har været flere meget positive resultater af deres lægemiddel kandidater.
-
Slyng1…Ja, har set de gode nyheder fra Cantargia, men det plejer markedet ikke belønne så meget
Hvor langt rækker pengekassen egentlig? -
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It. https://www.proinvestor.com/investornyt/1141743/viking-therapeutics-is-great-heres-why-you-shouldnt-buy-it
-
Vicore Pharma også på vej op af hullet fra bunden omkring kurs 13 til nu 18,4….er de små biotek selskaber generelt blevet attraktive igen efter en total udbombning?
-
Biotekselskab sigter mod milliardstor børsnotering https://borsen.dk/nyheder/virksomheder/dansk-biotekselskab-aabner-for-milliardstor-borsnotering?b_source=borsen&b_medium=row_0&b_campaign=news_2
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind